Synthetic antibodies with a human framework that protect mice from lethal Sudan ebolavirus challenge

Gang Chen, Jayne F. Koellhoffer, Samantha E. Zak, Julia C. Frei, Nina Liu, Hua Long, Wei Ye, Kaajal Nagar, Guohua Pan, Kartik Chandran, John M. Dye, Sachdev S. Sidhu, Jonathan R. Lai

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

(Chemical Equation Presented). The ebolaviruses cause severe and rapidly progressing hemorrhagic fever. There are five ebolavirus species; although much is known about Zaire ebolavirus (EBOV) and its neutralization by antibodies, little is known about Sudan ebolavirus (SUDV), which is emerging with increasing frequency. Here we describe monoclonal antibodies containing a human framework that potently inhibit infection by SUDV and protect mice from lethal challenge. The murine antibody 16F6, which binds the SUDV envelope glycoprotein (GP), served as the starting point for design. Sequence and structural alignment revealed similarities between 16F6 and YADS1, a synthetic antibody with a humanized scaffold. A focused phage library was constructed and screened to impart 16F6-like recognition properties onto the YADS1 scaffold. A panel of 17 antibodies were characterized and found to have a range of neutralization potentials against a pseudotype virus infection model. Neutralization correlated with GP binding as determined by ELISA. Two of these clones, E10 and F4, potently inhibited authentic SUDV and conferred protection and memory immunity in mice from lethal SUDV challenge. E10 and F4 were further shown to bind to the same epitope on GP as 16F6 with comparable affinities. These antibodies represent strong immunotherapeutic candidates for treatment of SUDV infection.

Original languageEnglish (US)
Pages (from-to)2263-2273
Number of pages11
JournalACS Chemical Biology
Volume9
Issue number10
DOIs
StatePublished - Oct 17 2014

Fingerprint

Ebolavirus
Sudan
Antibodies
Glycoproteins
Scaffolds
Bacteriophages
Viruses
Epitopes
Monoclonal Antibodies
Democratic Republic of the Congo
Data storage equipment
Sequence Alignment
Virus Diseases
Infection
Immunity
Fever
Clone Cells
Enzyme-Linked Immunosorbent Assay

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine

Cite this

Synthetic antibodies with a human framework that protect mice from lethal Sudan ebolavirus challenge. / Chen, Gang; Koellhoffer, Jayne F.; Zak, Samantha E.; Frei, Julia C.; Liu, Nina; Long, Hua; Ye, Wei; Nagar, Kaajal; Pan, Guohua; Chandran, Kartik; Dye, John M.; Sidhu, Sachdev S.; Lai, Jonathan R.

In: ACS Chemical Biology, Vol. 9, No. 10, 17.10.2014, p. 2263-2273.

Research output: Contribution to journalArticle

Chen, G, Koellhoffer, JF, Zak, SE, Frei, JC, Liu, N, Long, H, Ye, W, Nagar, K, Pan, G, Chandran, K, Dye, JM, Sidhu, SS & Lai, JR 2014, 'Synthetic antibodies with a human framework that protect mice from lethal Sudan ebolavirus challenge', ACS Chemical Biology, vol. 9, no. 10, pp. 2263-2273. https://doi.org/10.1021/cb5006454
Chen, Gang ; Koellhoffer, Jayne F. ; Zak, Samantha E. ; Frei, Julia C. ; Liu, Nina ; Long, Hua ; Ye, Wei ; Nagar, Kaajal ; Pan, Guohua ; Chandran, Kartik ; Dye, John M. ; Sidhu, Sachdev S. ; Lai, Jonathan R. / Synthetic antibodies with a human framework that protect mice from lethal Sudan ebolavirus challenge. In: ACS Chemical Biology. 2014 ; Vol. 9, No. 10. pp. 2263-2273.
@article{ddf35382f8d1448f9671b16d87bd8eda,
title = "Synthetic antibodies with a human framework that protect mice from lethal Sudan ebolavirus challenge",
abstract = "(Chemical Equation Presented). The ebolaviruses cause severe and rapidly progressing hemorrhagic fever. There are five ebolavirus species; although much is known about Zaire ebolavirus (EBOV) and its neutralization by antibodies, little is known about Sudan ebolavirus (SUDV), which is emerging with increasing frequency. Here we describe monoclonal antibodies containing a human framework that potently inhibit infection by SUDV and protect mice from lethal challenge. The murine antibody 16F6, which binds the SUDV envelope glycoprotein (GP), served as the starting point for design. Sequence and structural alignment revealed similarities between 16F6 and YADS1, a synthetic antibody with a humanized scaffold. A focused phage library was constructed and screened to impart 16F6-like recognition properties onto the YADS1 scaffold. A panel of 17 antibodies were characterized and found to have a range of neutralization potentials against a pseudotype virus infection model. Neutralization correlated with GP binding as determined by ELISA. Two of these clones, E10 and F4, potently inhibited authentic SUDV and conferred protection and memory immunity in mice from lethal SUDV challenge. E10 and F4 were further shown to bind to the same epitope on GP as 16F6 with comparable affinities. These antibodies represent strong immunotherapeutic candidates for treatment of SUDV infection.",
author = "Gang Chen and Koellhoffer, {Jayne F.} and Zak, {Samantha E.} and Frei, {Julia C.} and Nina Liu and Hua Long and Wei Ye and Kaajal Nagar and Guohua Pan and Kartik Chandran and Dye, {John M.} and Sidhu, {Sachdev S.} and Lai, {Jonathan R.}",
year = "2014",
month = "10",
day = "17",
doi = "10.1021/cb5006454",
language = "English (US)",
volume = "9",
pages = "2263--2273",
journal = "ACS Chemical Biology",
issn = "1554-8929",
publisher = "American Chemical Society",
number = "10",

}

TY - JOUR

T1 - Synthetic antibodies with a human framework that protect mice from lethal Sudan ebolavirus challenge

AU - Chen, Gang

AU - Koellhoffer, Jayne F.

AU - Zak, Samantha E.

AU - Frei, Julia C.

AU - Liu, Nina

AU - Long, Hua

AU - Ye, Wei

AU - Nagar, Kaajal

AU - Pan, Guohua

AU - Chandran, Kartik

AU - Dye, John M.

AU - Sidhu, Sachdev S.

AU - Lai, Jonathan R.

PY - 2014/10/17

Y1 - 2014/10/17

N2 - (Chemical Equation Presented). The ebolaviruses cause severe and rapidly progressing hemorrhagic fever. There are five ebolavirus species; although much is known about Zaire ebolavirus (EBOV) and its neutralization by antibodies, little is known about Sudan ebolavirus (SUDV), which is emerging with increasing frequency. Here we describe monoclonal antibodies containing a human framework that potently inhibit infection by SUDV and protect mice from lethal challenge. The murine antibody 16F6, which binds the SUDV envelope glycoprotein (GP), served as the starting point for design. Sequence and structural alignment revealed similarities between 16F6 and YADS1, a synthetic antibody with a humanized scaffold. A focused phage library was constructed and screened to impart 16F6-like recognition properties onto the YADS1 scaffold. A panel of 17 antibodies were characterized and found to have a range of neutralization potentials against a pseudotype virus infection model. Neutralization correlated with GP binding as determined by ELISA. Two of these clones, E10 and F4, potently inhibited authentic SUDV and conferred protection and memory immunity in mice from lethal SUDV challenge. E10 and F4 were further shown to bind to the same epitope on GP as 16F6 with comparable affinities. These antibodies represent strong immunotherapeutic candidates for treatment of SUDV infection.

AB - (Chemical Equation Presented). The ebolaviruses cause severe and rapidly progressing hemorrhagic fever. There are five ebolavirus species; although much is known about Zaire ebolavirus (EBOV) and its neutralization by antibodies, little is known about Sudan ebolavirus (SUDV), which is emerging with increasing frequency. Here we describe monoclonal antibodies containing a human framework that potently inhibit infection by SUDV and protect mice from lethal challenge. The murine antibody 16F6, which binds the SUDV envelope glycoprotein (GP), served as the starting point for design. Sequence and structural alignment revealed similarities between 16F6 and YADS1, a synthetic antibody with a humanized scaffold. A focused phage library was constructed and screened to impart 16F6-like recognition properties onto the YADS1 scaffold. A panel of 17 antibodies were characterized and found to have a range of neutralization potentials against a pseudotype virus infection model. Neutralization correlated with GP binding as determined by ELISA. Two of these clones, E10 and F4, potently inhibited authentic SUDV and conferred protection and memory immunity in mice from lethal SUDV challenge. E10 and F4 were further shown to bind to the same epitope on GP as 16F6 with comparable affinities. These antibodies represent strong immunotherapeutic candidates for treatment of SUDV infection.

UR - http://www.scopus.com/inward/record.url?scp=84908204878&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84908204878&partnerID=8YFLogxK

U2 - 10.1021/cb5006454

DO - 10.1021/cb5006454

M3 - Article

VL - 9

SP - 2263

EP - 2273

JO - ACS Chemical Biology

JF - ACS Chemical Biology

SN - 1554-8929

IS - 10

ER -